We report a patient with rheumatoid arthritis (RA) who developed leukoencephalopathy while being treated with low-dose methotrexate (MTX). She suddenly developed loss of recent memory and left homonymous hemianopsia ascribable to the bilateral but right-predominant occipitotemporal lesions. Intravenous administration of dexamethasone and cessation of MTX quickly relieved her clinical symptoms. Low-dose MTXinduced leukoencephalopathy is a rare complication in RA, but is important with regard to the possibility of serious neurological sequellae. © 2011 The Japanese Society of Internal Medicine.
CITATION STYLE
Matsuda, M., Kishida, D., Kinoshita, T., Hineno, A., Shimojima, Y., Fukushima, K., & Ikeda, S. I. (2011). Leukoencephalopathy induced by low-dose methotrexate in a patient with rheumatoid arthritis. Internal Medicine, 50(19), 2219–2222. https://doi.org/10.2169/internalmedicine.50.5552
Mendeley helps you to discover research relevant for your work.